Cytomegalovirus pp65 antigenaemia as an indicator of end-organ disease in AIDS

International Journal of STD and AIDS

Volumn 9, Issue 9, 1998, Pages 545-547

  Fox, E F ^a,b   Smith, N A ^a   Rice, P ^a   Dunn, H ^a   Peters, B S ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

AIDS; Antigens; Cytomegalovirus

Indexed keywords

CD4 ANTIGEN; CYTOMEGALOVIRUS ANTIBODY; GANCICLOVIR; STEROID; SYNAPTOTAGMIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADRENAL DISEASE; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; COLITIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FOLLOW UP; HEPATITIS; HUMAN; HUMAN TISSUE; IMMUNOASSAY; INTERMETHOD COMPARISON; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; POLYRADICULITIS; PRIORITY JOURNAL; PROGNOSIS; RETINITIS; TUBERCULOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIGENS, VIRAL; CYTOMEGALOVIRUS INFECTIONS; EVALUATION STUDIES; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; PHOSPHOPROTEINS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; VIRAL MATRIX PROTEINS;

EID: 0031690536     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462981922809     Document Type: Article

References (12)

1. Reichert CM, O'Leary TJ, Levens DL, Simrell CR, Macher AM. Autopsy pathology in the acquired immunodeficiency syndrome. Am J Pathol 1983;112:357-82
2. Jacobson MA, Mills J. Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988;108:585-94
3. Spector SA, McKinley GF, Lalezari JP, et al. Oral ganciclovir for the prevention of cvtomegalovirus disease in persons with AIDS. N Engl J Med 1996;334(23):1491-7
4. Bek B, Boeckh M, Lepenies J, et al. High level sensitivity of quantitative pp65 cytomegalovirus (CMV) antigenaemia assay for diagnosis of CMV disease in AIDS patients and follow-up. J Clin Microbiol 1996;34(2):457-9
5. Erice A, Holm MA, Gill PC, et al. Cytomegalovirus (CMV) antigenaemia assay is more sensitive than shell vial culture for rapid detection of CMV in polymorphonuclear blood leucocytes. J Clin Microbiol 1992;30(11):2822-5
6. Salzberger B, Franzen C, Fatkenheuer G, et al. CMV antigenaemia in peripheral blood for the diagnosis of CMV disease in HIV-infected patients. J AIDS Hum Ret 1996;11: 365-9
7. Wetherill PE, Landry ML, Alcabes P, Friedland G. Use of quantitative cytomegalovirus (CMV) antigenaemia test in evaluating HIV+ patients with and without CMV disease. J AIDS Hum Ret 1996;12(1):33-7
8. Pillay D, Griffiths PD. Diagnosis of cytomegalovirus infection: a review. Genitourin Med 1992;68:183-8
9. Dodt KK, Jacobsen PH, Hofmann B, et al. Development of cytomegalovirus (CMV) disease may be predicted in HIV-infected patients by CMV polymerase chain reaction and the antigenaemia tests. AIDS 1997;11:F21-28
10. Francisci D, Tosti A, Preziosi R, Baldelli F, Stagni G, Pauluzzi S. Role of antigenaemia assay in the early diagnosis and prediction of human cytomegalovirus organ involvement in AIDS patients. Eur J Clin Microbiol Infect Dis 1951;14(6):498-503
11. Landry ML, Ferguson D. Comparison of quantitative cytomegalovirus antigenaemia assay with culture methods and correlation with clinical disease. J Clin Microbiol 1993;33(11):2851-6
12. Gerna G, Parea M, Percivalle E, et al. Human cytomegalovirus viraemia in HIV-1-seropositive patients at various clinical stages of infection. AIDS 1990;4(10):1027-31